Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment

被引：0
|
作者：
Rafael Morales-Barrera
Guillermo Villacampa
Natalia Vidal
Mariona Figols
Julia Giner
Teresa Bonfill
Cristina Suárez
Nely Díaz
Joaquín Mateo
Macarena González
Montserrat Domenech
Javier Puente
Joan Carles
机构：
[1] Vall d’Hebron Institute of Oncology,Department of Medical Oncology
[2] Vall d’ Hebron University Hospital,Oncology Data Science (OdysSey) Group
[3] Universitat Autònoma de Barcelona,Medical Oncology Department
[4] Vall d’Hebron Institute of Oncology (VHIO),Medical Oncology Department
[5] The Institute of Cancer Research,Medical Oncology
[6] Hospital Clínico San Carlos,undefined
[7] Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC),undefined
[8] CIBERONC,undefined
[9] Fundació Althaia Manresa,undefined
[10] Parc Taulí Hospital Universitari,undefined
[11] Institut d’Investigació i Innovació Parc Taulí I3PT,undefined
来源：
Clinical and Translational Oncology | 2023年 / 25卷
关键词：
Immune checkpoint inhibitors; Immune-related adverse events; Overall response rate; Survival; Urothelial carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3556 / 3564
页数：8
相关论文
共 50 条
  • [41] Sargramostim for Prophylactic Management of Gastrointestinal Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy for Cancer
    Dougan, Michael
    Nguyen, Long H.
    Buchbinder, Elizabeth I.
    Lazarus, Hillard M.
    CANCERS, 2024, 16 (03)
  • [42] Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab
    Furubayashi, Nobuki
    Minato, Akinori
    Negishi, Takahito
    Sakamoto, Naotaka
    Song, Yoohyun
    Hori, Yoshifumi
    Tomoda, Toshihisa
    Harada, Mirii
    Tamura, Shingo
    Miura, Akihiro
    Komori, Hiroki
    Kuroiwa, Kentaro
    Seki, Narihito
    Fujimoto, Naohiro
    Nakamura, Motonobu
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1641 - 1651
  • [43] Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors
    Kottschade, Lisa A.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (03)
  • [44] Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
    Abou Alaiwi, Sarah
    Xie, Wanling
    Nassar, Amin H.
    Dudani, Shaan
    Martini, Dylan
    Bakouny, Ziad
    Steinharter, John A.
    Nuzzo, Pier Vitale
    Flippot, Ronan
    Martinez-Chanza, Nieves
    Wei, Xiao
    McGregor, Bradley A.
    Kaymakcalan, Marina D.
    Heng, Daniel Y. C.
    Bilen, Mehmet A.
    Choueiri, Toni K.
    Harshman, Lauren C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [45] Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors
    Lisa A. Kottschade
    Current Oncology Reports, 2018, 20
  • [46] Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors
    Shimozaki, Keitaro
    Sukawa, Yasutaka
    Beppu, Noriko
    Kurihara, Isao
    Suzuki, Shigeaki
    Mizuno, Ryuichi
    Funakoshi, Takeru
    Ikemura, Shinnosuke
    Tsugaru, Kai
    Togasaki, Kazuhiro
    Kawasaki, Kenta
    Hirata, Kenro
    Hayashi, Hideyuki
    Hamamoto, Yasuo
    Takaishi, Hiromasa
    Kanai, Takanori
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4585 - 4593
  • [47] Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors
    Hu, Xiao
    Rodday, Angie Mae
    Gurinovich, Anastasia
    Pan, Stacey
    Salei, Yana V.
    Lin, Jeffrey H.
    Byrne, Margaret M.
    Cao, Yu
    Pai, Lori
    Parsons, Susan K.
    IMMUNOTHERAPY, 2025, : 321 - 329
  • [48] Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy
    Dionese, Michele
    Bimbatti, Davide
    Pierantoni, Francesco
    Lai, Eleonora
    Erbetta, Elisa
    Cavasin, Nicolo
    Jubran, Salim
    Basso, Umberto
    Maruzzo, Marco
    ANTICANCER RESEARCH, 2024, 44 (10) : 4379 - 4386
  • [49] Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
    Hribernik, Nezka
    Huff, Daniel T.
    Studen, Andrej
    Zevnik, Katarina
    Klanecek, Zan
    Emamekhoo, Hamid
    Skalic, Katja
    Jeraj, Robert
    Rebersek, Martina
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (06) : 1857 - 1869
  • [50] Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
    Nežka Hribernik
    Daniel T Huff
    Andrej Studen
    Katarina Zevnik
    Žan Klaneček
    Hamid Emamekhoo
    Katja Škalic
    Robert Jeraj
    Martina Reberšek
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 1857 - 1869
12345